Dr. Olalekan Olanipekun, MD

Dr. Olanipekun practices at South Pointe Hospital in Warrensville Heights, Ohio, part of The Cleveland Clinic Foundation.

Dr. Olanipekun's NPI, 1689170680, was assigned on March 30, 2018. Dr. Olanipekun holds Ohio license 35.149588.

Dr. Olanipekun's primary practice is South Pointe Hospital, at 20000 Harvard Road, Warrensville Heights, OH 44122 in Cuyahoga County. The practice phone is (216) 491-6523.

Dr. Olanipekun's primary practice is South Pointe Hospital in Warrensville Heights, Ohio, part of The Cleveland Clinic Foundation. Dr. Olanipekun is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Olanipekun to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olanipekun practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Olanipekun's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Olanipekun is licensed in Ohio.

CMS data shows 183 Medicare services from Dr. Olanipekun across 8 procedure codes in 2024, for 84 Medicare patients. Medicare paid $2,720 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 84 Medicare patients who saw Dr. Olanipekun in 2024. The largest group is 75 to 84, with 28 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Olanipekun's median patient age at 67, with 54% women.

In 2024, Dr. Olanipekun wrote 282 Medicare Part D claims for 73 patients. 89% of them were for generic drugs. CMS names the drug for 228 of them, across 13 drugs with 11 or more claims each, at $15,442 in total drug cost. In 2023, CMS named 426 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Olanipekun for performance year 2024, reported through an alternative payment model (APM). Dr. Olanipekun accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Olanipekun, published from 2019 to 2024. 2020 was the busiest year, with 3. Dr. Olanipekun has published most often in Cureus. Dr. Olanipekun's most frequent co-authors are Rodrigo Aguilar, MD, Solomon Neba Ambe, MD and Nicolas Bakinde, MD, PhD.

CMS Open Payments shows 52 general payments to Dr. Olanipekun from 10 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 78% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $380.